equityflowunderstand the flow and follow it

Formation Bio

Healthtech · New York, US

AI-driven drug development company streamlining pharma R&D.

Founders

Benjamine Liu (United States · ♂) — A Rhodes Scholar computational biologist who, watching clinical trials bottleneck new treatments during his Oxford PhD, founded TrialSpark (now Formation Bio) to accelerate drug development.
Linhao Zhang (China/US · ♂) — A computer-science engineer who met co-founder Kit Dobyns at Salesforce and co-founded TrialSpark (now Formation Bio) in 2016, serving as its founding CTO.
Kit Dobyns (US · ♂) — A Cornell graduate and Rhodes Scholar who co-founded TrialSpark (now Formation Bio) in 2016 before leaving in 2019 to start Cayaba Care.
Don DeGolyer

Team & hubs

People & leadership

Benjamine Liu CEO at Formation BioAna Romo Chief Technology Officer at RADBIODon DeGolyer Founder, Senior Advisor and Board MemberDave Lu Managing Partner of Hyphen Capital | Host of Hyphen Nation | Co-founder of Asian Leadership Center and Stand With Asian Americans | Emmy-winning Producer of 38 at the Garden | Advisory Board of Smithsonian APAC

Funding history

Date	Round	Amount
Jun 2024	Series D Plus Formation Bio, a US AI drug-development startup, raised a $372M Series D led by Andreessen Horowitz, bringing total funding above $600M.	$372M

Investors

Tap an investor to see what else they have backed.

Andreessen Horowitz

Other companies in Healthtech

OurMind TurnUp Nanordica Medical Uncovr 01Health Rem3dy Health Joyvié Health Semble Triomics Musely VITL Ema Health

Other companies in US

Supabase Groq Corgi Triomics Stord Patina Status AI Stilta Nectar Social Synthetic Kalshi Musely

Other companies at Series D Plus stage

ACKO AMP Robotics APrevent AVIOM Housing Finance Abridge Acorns Adverity Agile Robots AgroStar Aidoc Aircall Airwallex

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.